Artificial Intelligence and Machine Learning in Drug Design and Development
Khanna, A (Author)
Sold by Revaluation Books, Exeter, United Kingdom
AbeBooks Seller since 6 January 2003
New - Hardcover
Condition: New
Quantity: 2 available
Add to basketSold by Revaluation Books, Exeter, United Kingdom
AbeBooks Seller since 6 January 2003
Condition: New
Quantity: 2 available
Add to basket400 pages. 7.00x1.50x10.00 inches. In Stock.
Seller Inventory # __1394234163
The book is a comprehensive guide that explores the use of artificial intelligence and machine learning in drug discovery and development covering a range of topics, including the use of molecular modeling, docking, identifying targets, selecting compounds, and optimizing drugs.
The intersection of Artificial Intelligence (AI) and Machine Learning (ML) within the field of drug design and development represents a pivotal moment in the history of healthcare and pharmaceuticals. The remarkable synergy between cutting-edge technology and the life sciences has ushered in a new era of possibilities, offering unprecedented opportunities, formidable challenges, and a tantalizing glimpse into the future of medicine.
AI can be applied to all the key areas of the pharmaceutical industry, such as drug discovery and development, drug repurposing, and improving productivity within a short period. Contemporary methods have shown promising results in facilitating the discovery of drugs to target different diseases. Moreover, AI helps in predicting the efficacy and safety of molecules and gives researchers a much broader chemical pallet for the selection of the best molecules for drug testing and delivery. In this context, drug repurposing is another important topic where AI can have a substantial impact. With the vast amount of clinical and pharmaceutical data available to date, AI algorithms find suitable drugs that can be repurposed for alternative use in medicine.
This book is a comprehensive exploration of this dynamic and rapidly evolving field. In an era where precision and efficiency are paramount in drug discovery, AI and ML have emerged as transformative tools, reshaping the way we identify, design, and develop pharmaceuticals. This book is a testament to the profound impact these technologies have had and will continue to have on the pharmaceutical industry, healthcare, and ultimately, patient well-being.
The editors of this volume have assembled a distinguished group of experts, researchers, and thought leaders from both the AI, ML, and pharmaceutical domains. Their collective knowledge and insights illuminate the multifaceted landscape of AI and ML in drug design and development, offering a roadmap for navigating its complexities and harnessing its potential. In each section, readers will find a rich tapestry of knowledge, case studies, and expert opinions, providing a 360-degree view of AI and ML’s role in drug design and development. Whether you are a researcher, scientist, industry professional, policymaker, or simply curious about the future of medicine, this book offers 19 state-of-the-art chapters providing valuable insights and a compass to navigate the exciting journey ahead.
Audience
The book is a valuable resource for a wide range of professionals in the pharmaceutical and allied industries including researchers, scientists, engineers, and laboratory workers in the field of drug discovery and development, who want to learn about the latest techniques in machine learning and AI, as well as information technology professionals who are interested in the application of machine learning and artificial intelligence in drug development.
Abhirup Khanna is an accomplished professional currently working as an assistant professor at the University of Petroleum and Energy Studies, Dehradun, India. He is an alumnus of The University of Melbourne, Australia. He has authored two books and numerous research publications in the areas of AI, blockchain technology, Internet of Things, and Cloud Computing for international journals and conferences. His research profile demonstrates his commitment to pushing the boundaries of AI and blockchain technology and his potential to drive transformative changes in these fields.
May El Barachi, PhD, is the Director of Computer Science & IT Programs at the University of Wollongong in Dubai, UAE. An Egyptian-Canadian computer scientist, and smart technology expert with degrees in telecom, engineering, computer engineering, and computer science, Dr. El Barachi holds leadership roles in teaching/learning and research. In her current role, she defines the research strategy for the faculty and ensures that the right ecosystem is established for conducting high-impact research.
Sapna Jain, PhD, is an assistant professor at the University of Petroleum and Energy Studies, Dehradun, India. She has earned her PhD in ‘Synthesis of novel bioactive compounds’ from Delhi University. She has published various research papers in renowned national and international journals, as well as two patents concerning the application of a synergistic combination of synthetic and natural products as an antifungal agent.
Manoj Kumar, PhD, is an associate professor at the University of Wollongong in Dubai, UAE as well as the Research Head for Network and Cyber Security Cluster at the university. He obtained his PhD from The Northcap University, Haryana, India. Dr. Kumar has more than 14 years of research, teaching, and corporate experience, and has published more than 175 research articles in international refereed journals and conferences.
Anand Nayyar, PhD, obtained his doctorate from Desh Bhagat University, Punjab, India in 2017 and is currently an assistant professor at the School of Computer Science, Duy Tan University, Viet Nam. He is also the Vice-Chairman of Research and Director of the IoT and Intelligent Systems Lab at Duy Tan University. He has published more than 180 research articles in international refereed journals, 50 books, and has 100+ patents to his credit. He has more than 12,000 citations on Google Scholar.
"About this title" may belong to another edition of this title.
Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch
If you are a consumer you can cancel the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
INFORMATION REGARDING THE RIGHT OF CANCELLATION
Statutory Right to cancel
You have the right to cancel this contract within 14 days without giving any reason.
The cancellation period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the the last good or the last lot or piece.
To exercise the right to cancel, you must inform us, Revaluation Books, Exstowe, Exton, EX3 0PP, Exeter, United Kingdom, 44 1179083586, of your decision to cancel this contract by a clear statement (e.g. a letter sent by post, fax or e-mail). You may use the attached model cancellation form, but it is not obligatory. You can also electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". If you use this option, we will communicate to you an acknowledgement of receipt of such a cancellation on a durable medium (e.g. by e-mail) without delay.
To meet the cancellation deadline, it is sufficient for you to send your communication concerning your exercise of the right to cancel before the cancellation period has expired.
Effects of cancellation
If you cancel this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to cancel with contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to us or Revaluation Books, Edward Bowditch Ltd, Clifton Heights, Triangle West, BS8 1EJ, Bristol, United Kingdom, 44 1179083586, without undue delay and in any event not later than 14 days from the day on which you communicate your cancellation from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of cancellation
The right of cancellation does not apply to:
Model withdrawal form
(complete and return this form only if you wish to withdraw from the contract)
To: (Revaluation Books, Exstowe, Exton, EX3 0PP, Exeter, United Kingdom, 44 1179083586)
I/We (*) hereby give notice that I/We (*) withdraw from my/our (*) contract of sale of the following goods (*)/for the provision of the following goods (*)/for the provision of the following service (*),
Ordered on (*)/received on (*)
Name of consumer(s)
Address of consumer(s)
Signature of consumer(s) (only if this form is notified on paper)
Date
* Delete as appropriate.
Orders usually dispatched within two working days.
| Order quantity | 7 to 14 business days | 2 to 3 business days |
|---|---|---|
| First item | £ 15.00 | £ 15.00 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.